Precision Genome Engineering
Precision Genome Engineering
批准号:
10391367
负责人:
Thale Cross Jarvis
金额:
$2.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2023-01-31
关键词:
AddressAgricultural DevelopmentBenchmarkingBiologicalBiologyBritish ColumbiaCRISPR/Cas technologyCanadaCell TherapyCell modelCellsClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsDataDevelopmentDiseaseEducational workshopEpigenetic ProcessEquilibriumEthicsEventGenderGene ExpressionGenesGenomeGenome engineeringGenomic approachGenomicsHearingJointsKnowledgeLearningMentorsMethodologyMolecularOutcomePainParticipantProcessPublicationsPublishingResearchResearch PersonnelScienceScientistStressTherapeuticTimeTissuesUnderrepresented PopulationsUpdatebasebiological researchcareercatalystclinical practicecoronavirus diseasedesignfunctional genomicsgenome editinginnovationinterestmeetingsnew technologynew therapeutic targetnext generationpostersprogramsreal world applicationsuccesssymposiumtherapy developmenttooltranslational scientist
中文摘要
摘要
请求支持举办的题为《精密基因组工程》的Keystone研讨会
作者:Jacob E.Corn,Kathy K.Niakan和Cecilia Cotta-Ramusino。会议将在惠斯勒举行,
加拿大不列颠哥伦比亚省,2022年2月13日至17日。
精确基因组工程彻底改变了生物学研究,并正在使
治疗的突破性进展。进展迅速,研究人员见面和建立网络的能力
为了跟上该领域的最新进展,这是至关重要的。本次会议将聚焦于新的
基础CRISPR-CAS生物学,创造新的基因组工程工具(CRISPR-CAS和
否则),提供新的生物应用的最新进展,并讨论应用的最新进展
走向市场,如治疗和农业开发。Keystone研讨会
CRISPR会议一直是该领域的基准,吸引了大量观众。接下来的
创造性的新工具的开发和向现实世界应用的进一步进展将是一个巨大的吸引力
对参与者而言。这次会议还将包括关于伦理问题的研讨会和小组讨论,这将丰富
科学计划。最后,本次会议将与Keystone研讨会会议联合举行
新兴的细胞疗法。这是一个理想的配对,因为基因组工程已经成为这一领域的必备条件
竞技场。基因组工程师的与会者将受益于了解该领域的痛点和缺失片段
细胞疗法,和细胞疗法的参与者将受益于听到关于快速-
基因组工程的有节奏的领域。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Precision Genome Engineering, organized
by Drs. Jacob E. Corn, Kathy K. Niakan and Cecilia Cotta-Ramusino. The conference will be held in Whistler,
British Columbia, Canada from February 13-17, 2022.
Precision genome engineering has completely revolutionized biological research and is making
groundbreaking inroads to therapies. Progress is rapid and the ability for researchers to meet and network is
essential in order to stay updated with the latest advances in the field. This conference will focus on new
fundamental CRISPR-Cas biology, creation of new genome engineering tools (both CRISPR-Cas and
otherwise), provide updates on new biological applications, and discuss the latest advances on applications
moving towards market, such as therapies and agricultural developments. The Keystone Symposia
conference on CRISPR has been a benchmark of the field and draws large audiences. The continued
development of creative new tools and further progress towards real-world application will be a big attraction
for participants. This conference will also include workshops and panels on ethical questions that will enrich
the scientific program. Finally, this meeting will be held jointly with the Keystone Symposia conference
Emerging Cellular Therapies. This is an ideal pairing as genome engineering has become de rigueur in this
arena. Genome engineer attendees will benefit by learning pain points and missing pieces in the field of
cellular therapy, and cell therapy attendees will benefit by hearing about the latest breakthroughs in the fast-
paced field of genome engineering.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Humoral Immunity: From Regulation to Dysregulation
-
批准号:10469165
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
海外基金